Tirzepatide Without Insurance: Costs and Access
Insurance doesn't cover everyone — and even when it does, GLP-1 weight loss medications are often excluded. The good news: there are several legitimate ways to access tirzepatide without insurance. Here's an honest, plain-English breakdown of every option, what it costs, and what to ask before you start.
Key takeaways
Without insurance, brand-name Zepbound® at retail pharmacies costs around $1,086/month. LillyDirect® self-pay vials run $299–$449/month depending on dose.
The Zepbound® Savings Card may lower costs to as little as $25/month — but only if you have commercial insurance that already partially covers it.
Compounded tirzepatide through licensed providers like Ondra Health starts at $183/month on a quarterly plan, with the same price across every dose.
Compounded medications are not FDA-approved and aren't reviewed by the FDA for safety, effectiveness, or manufacturing quality.
Hidden costs, including labs, follow-ups, and supplies, can add $200–$700/year on top of medication. Some telehealth providers bundle these services into their pricing.
Quick answer: what does tirzepatide cost without insurance?
It depends on the path you choose. Here's the short version:
If you have no insurance and want brand-name Zepbound, LillyDirect self-pay vials run about $299/month at the starting dose, $399 at 5 mg, and $449 at higher doses.
If you want brand-name Zepbound pens at a retail pharmacy, the list price is around $1,086/month before any discounts.
If you're open to compounded tirzepatide through a licensed telehealth provider like Ondra Health, prices start at $183/month on a quarterly plan or $219/month on a monthly plan, with no hidden fees and the same price across every dose level.
Manufacturer pricing changes — Lilly cut its self-pay vial prices in December 2025 — so verify current figures at lillydirect.lilly.com before deciding. Now let's break down every option in detail.
What "without insurance" actually means
"Without insurance" doesn't always mean uninsured. Most people in this situation fall into one of these buckets:
Your plan excludes GLP-1s for weight loss
Many commercial plans cover Mounjaro® for type 2 diabetes but exclude Zepbound® for weight loss. Same active ingredient, different label, different coverage rules.
High deductible, not yet met
Even if your plan technically covers it, you may be paying out of pocket until you hit your deductible — sometimes thousands of dollars.
Prior authorization denied
Insurers often require step therapy, such as proof that you tried other medications first, before approving GLP-1 treatment. Many people are denied on the first try.
Government insurance
Medicare, Medicaid, VA, and TRICARE generally do not cover GLP-1s for weight loss, and patients on these plans aren't eligible for manufacturer savings cards. Coverage rules in this area have been changing — check your current plan directly.
No insurance at all
Self-employed, between jobs, or simply uninsured — cash-pay options are your only path here.
Every cash-pay option, side by side
Brand-name and manufacturer program pricing changes frequently — verify current figures directly with Lilly before deciding. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or manufacturing quality.
Option 1: Zepbound® Savings Card — lowest cost, narrow eligibility
If you have commercial insurance that partially covers Zepbound®, the manufacturer savings card can drop your monthly cost to as low as $25. This is by far the cheapest legitimate access path — but eligibility is strict.
Who qualifies
You must have commercial private health insurance that covers Zepbound®. Patients on Medicare, Medicaid, VA, TRICARE, or other government plans are not eligible for the savings card.
If your commercial plan doesn't cover Zepbound®
Lilly offers separate self-pay options, described below. Savings card terms, caps, and eligibility change — check current details at zepbound.lilly.com.
The Mounjaro® Savings Card works similarly for patients with type 2 diabetes whose commercial insurance covers Mounjaro®.
Option 2: LillyDirect® self-pay vials
LillyDirect® is Eli Lilly's direct-to-patient platform. It sells single-dose vials of brand-name Zepbound® at lower prices than retail pharmacy pens. Lilly reduced these prices in December 2025, so older articles and comparison pages often quote figures that are no longer current.
Prices reflect Lilly's self-pay vial program following its December 2025 price reduction. For doses of 7.5 mg and above, the $449 price depends on staying enrolled in Lilly's self-pay program, which requires completing each refill within 45 days of your previous delivery. Missing that window may require re-enrollment. Verify current pricing and program terms at lillydirect.lilly.com.
The catch
LillyDirect self-pay pricing covers single-dose vials, not the prefilled pens available at retail. Patients draw the medication into a syringe themselves, and syringes, needles, and alcohol swabs are purchased separately. For some patients, this is fine. Others may prefer the convenience of a pen.
Option 3: Retail pharmacy — brand-name pens at full price
If you walk into a retail pharmacy and pay cash for Zepbound® pens without any program, the list price is approximately $1,086 per month. Mounjaro® pens are similarly priced.
This is rarely the most affordable option for cash-pay patients. Either LillyDirect or compounded alternatives generally cost less. The main reason to choose retail may be that you specifically want the auto-injector pen or cannot route your prescription through a self-pay program.
Option 4: Compounded tirzepatide
Compounded medications are prepared by state-licensed compounding pharmacies for individual patients. They are not FDA-approved.
Why people choose this path
Cost. Compounded tirzepatide is generally less expensive than brand-name medication. It is also often available in vial form, sometimes with additives like B12 or glycine. These additives are not present in the brand-name product and have not been reviewed by the FDA in this context.
What "not FDA-approved" actually means
Compounded medications aren't reviewed by the FDA for safety, effectiveness, or manufacturing quality and are not therapeutically equivalent to brand-name products. The compounding pharmacies themselves are state-licensed and inspected. A licensed provider must determine that a compounded version is clinically appropriate for you specifically — it isn't a substitute for FDA-approved options for everyone.
What to look for in a compounded provider
Use a state-licensed pharmacy with a valid prescription from a licensed provider. Avoid anyone selling tirzepatide without a prescription, refusing to disclose their pharmacy partners, or offering "research-grade" peptides online. Those are not legitimate sources of prescription medication.
At Ondra Health, compounded tirzepatide pricing is straightforward:
The hidden costs nobody talks about
The medication isn't your only expense. Here's what to budget for over a full year:
Initial consultation
$50–$300 for in-person visits. Most telehealth platforms, including Ondra Health, include the initial provider review at no separate charge. You only pay if you're prescribed treatment.
Baseline labs
$100–$300 if your provider requires bloodwork before starting. Some platforms include this; others bill separately. Ask before you sign up.
Follow-up visits
$75–$150 every 1–3 months in traditional care. At Ondra and similar telehealth providers, ongoing provider messaging is included in the monthly price.
Monitoring labs
$100–$300 every 3–6 months if your provider orders them. Whether you need monitoring labs is a clinical decision for your provider.
Supplies
Syringes, alcohol swabs, and sharps disposal are relevant when using vials. Pen products include their own injectors. Ondra's plans include injection supplies.
How costs change as your dose increases
Tirzepatide follows a dose-escalation schedule, starting at 2.5 mg and increasing under provider guidance. Different access paths handle this very differently:
LillyDirect: price steps up with dose
You start at $299/month for 2.5 mg, step to $399 at 5 mg, and then $449 at 7.5 mg and above. The $449 tier depends on refilling within 45 days of your previous delivery to stay enrolled in Lilly's self-pay program.
Retail pharmacy: same price across most doses
Brand-name pens are approximately $1,086/month regardless of dose, before any savings programs.
Ondra Health: flat price across every dose
Whether you're at the 2.5 mg starting dose or the 15 mg maximum dose, your cost is the same: $219 monthly or $183/month on a quarterly plan. There is no price increase as you titrate.
What every provider checks before prescribing
Regardless of how you pay, a licensed provider must determine that tirzepatide is clinically appropriate for you. Expect them to review:
BMI and weight history
Tirzepatide is generally indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, such as type 2 diabetes, hypertension, sleep apnea, or high cholesterol.
Personal and family medical history
Tirzepatide is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome. It is also contraindicated during pregnancy. Tell your provider if you are pregnant, may become pregnant, or are breastfeeding.
Current medications and conditions
Your provider will check for drug interactions and review conditions such as a history of pancreatitis, severe gallbladder disease, gastroparesis, and certain kidney issues.
Lifestyle factors
GLP-1 medications are prescribed alongside dietary changes and physical activity. Most providers want to see a commitment to broader lifestyle support, not medication alone.
Questions to ask before you commit
Whatever path you choose, get clear answers to these questions before paying:
Pricing transparency
What's the all-in monthly cost? Does it change as my dose increases? What's the 12-month total at the highest dose I might reach?
What's included vs. extra
Are provider visits, messaging, follow-ups, labs, supplies, and shipping included or billed separately?
Cancellation and refunds
Can I cancel anytime? What happens if my provider doesn't approve me? Am I charged at all?
Pharmacy partners
For compounded options, which pharmacies do you use? Are they state-licensed? Can I verify their licensure with my state board?
Long-term plan
What does ongoing treatment look like? If I need to stop, what does my provider recommend?
One thing to plan for: what happens if you stop
Weight regain after stopping a GLP-1 is common. Trial data shows that many participants regain a meaningful portion of lost weight within a year of discontinuation. Before starting, think about long-term affordability. The medication that's right for you isn't just the least expensive option — it's one you can sustain long enough to support your treatment goals.
If you need to stop because of cost, side effects, or life changes, speak with your provider rather than changing treatment on your own. Any change to your treatment plan is a clinical decision.
The bottom line
Tirzepatide without insurance is more accessible than it used to be. Brand-name options through LillyDirect have brought FDA-approved tirzepatide to $299–$449/month for cash-pay patients. Compounded alternatives through licensed providers like Ondra Health are lower still, starting at $183/month, with the trade-off of FDA approval status. That distinction is important and should not be treated as a technicality.
The right path depends on your priorities: FDA-approved medication, transparent flat pricing, the lowest possible cost, or pen versus vial convenience. Whatever you choose, work with a licensed provider, ask about hidden costs, verify current manufacturer pricing directly, and plan for long-term treatment rather than only the first month.
Frequently asked questions
How can I get tirzepatide without insurance?
There are three main cash-pay paths: Eli Lilly's LillyDirect self-pay vials for Zepbound at $299–$449/month depending on dose, retail-pharmacy brand-name pens at approximately $1,086/month, and compounded tirzepatide through licensed providers and pharmacies, such as Ondra Health, starting at $183/month on a quarterly plan. Separately, the Zepbound Savings Card can lower costs to as little as $25/month, but only if your commercial insurance already partially covers Zepbound.
How much does tirzepatide cost without insurance?
It varies widely by access path. Brand-name Zepbound pens list at about $1,086/month at retail pharmacies. LillyDirect single-dose vials are $299 for the 2.5 mg starting dose, $399 for 5 mg, and $449 for 7.5 mg and above. Compounded tirzepatide through Ondra Health is $219/month on a monthly plan or $183/month on a quarterly plan, with the same price across all dose levels. Manufacturer pricing changes, so verify current figures directly.
Is compounded tirzepatide cheaper than brand-name?
Generally, yes. At Ondra Health, compounded tirzepatide starts at $183/month on a quarterly plan, compared with $299–$449/month for LillyDirect vials and approximately $1,086/month for retail-pharmacy Zepbound pens. The trade-off is regulatory: compounded medications are not FDA-approved, so the FDA has not reviewed them for safety, effectiveness, or manufacturing quality, and they are not therapeutically equivalent to brand-name products.
Who qualifies for tirzepatide?
FDA labeling for Zepbound generally indicates use in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, or sleep apnea. Tirzepatide should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome and is contraindicated during pregnancy. A licensed provider determines suitability.
What hidden costs should I budget for beyond the medication?
Beyond the prescription itself, costs may include an initial provider consultation, baseline lab work, follow-up visits, periodic monitoring labs, and supplies for vial-based medication. Some platforms, including Ondra, bundle supplies and provider messaging into the plan price.
What happens to costs as my dose increases?
It depends on the access path. LillyDirect vial pricing steps up with dose: $299 at 2.5 mg, $399 at 5 mg, and $449 at 7.5 mg and above, with the $449 tier requiring timely refills under the program terms. Ondra Health uses flat pricing across all available dose levels, meaning your plan price stays the same whether you're at the 2.5 mg starting dose or the 15 mg maximum dose.
† This article is for educational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety, effectiveness, or manufacturing quality, and are not therapeutically equivalent to brand-name products. Brand-name, manufacturer program, and savings card pricing referenced here reflects publicly available information at the time of writing and changes frequently. Figures should be verified directly at lillydirect.lilly.com and zepbound.lilly.com before making a decision. Brand names, including Zepbound®, Mounjaro®, and LillyDirect®, are referenced for informational purposes only and remain the property of Eli Lilly and Company. Ondra Health is not affiliated with, sponsored by, or endorsed by Eli Lilly. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment plan.